ASIATODAY

BIZ&TECH

Samsung Bioepis starts Phase 1 trial for SBE303 ADC

Samsung Bioepis announced Tuesday the initiation of a Phase 1 clinical trial for SBE303, its first novel antibody-drug conjugate (ADC) candidate targeting Nectin-4.SBE303 is designed to bind to Nectin-4, an adhesion protein specifically expressed in tumor cells, including urothelial, lung, and breast cancers. The company said the candidate represents a signi..

Hyundai, Kia face $1.3 billion Q3 profit hit from tariffs
Hyundai Motor and Kia are bracing for a sharp earnings decline in the third quarter as the prolonged U.S.–Korea tariff standoff weighs heavily on Korea’s a..

previous block

11 12 13 14 15 16 17 18 19 20

next block

Most Read

1

Samsung rides chip super cycle, eyes global No.1 p..

2

Samsung labor seeks 40 trillion won bonus, pressur..

3

SK hynix set to join Samsung surge

4

Hyundai’s 9trn won Saemangeum project gains moment..

5

US-Iran tensions escalate as Trump orders naval bl..

6

Lee to hold summit with Polish PM Tusk on April 13

7

Gulf states rush for Korean air defense systems

PEOPLE

“Hallyu ban to be removed quickly”: Hopes of thaw in Seoul-Beijing ties: · “Efforts will be made to remove Hallyu ban quickly”; · SK Group Chairman heads to Japan to soften “WD risk”

PHOTO

Jang Won-young shines as BVLGARI’s holiday muse

S.KOREA

POLITICS

SOCIAL AFFAIRS

WORLD

CHINA

INDIA

OTHERS

ECONOMY

BIZ&TECH

CULTURE

PEOPLE

PHOTO

Address : In-Young Bldg., 34, Uisadang-daero 1-gil, Yeongdeungpo-gu, Seoul

Copyright by ASIATODAY CO., LTD. All rights resereved